Lovastatin restores the function of endothelial progenitor cells damaged by oxLDL

Acta Pharmacologica Sinica

Volumn 30, Issue 5, 2009, Pages 545-552

  Ma, Feng Xia ^a   Chen, Fang ^a   Ren, Qian ^a   Han, Zhong Chao ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Endothelial nitric oxide synthase; Endothelial progenitor cells; Oxidized low density lipoprotein

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; MEVINOLIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; TRICIRIBINE;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; WESTERN BLOTTING;

ANTIGENS, CD34; APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LIPOPROTEINS, LDL; LOVASTATIN; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 66749150078     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.41     Document Type: Article

References (21)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
2. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002; 30: 967-72.
3. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006; 47: 1227-37.
4. Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004; 31: 407-13.
5. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. Te efect of pravastatin on coronary events afer myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-9.
6. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72.
7. Levadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001;108: 399-405.
8. Ma FX, Han ZC. Akt signaling and its role in postnatal neovascu-larization. Histol Histopathol 2005; 20: 275-81.
9. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.
10. Guthrie SM, Curtis LM, Mames RN, Simon GG, Grant MB, Scot EW. Te nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood 2005; 105: 1916-22.
11. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-meth-ylglutaryl coenzyme a reductase inhibitors. Arterioscler Tromb Vasc Biol 2001; 21: 1712-9.
12. Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Ros-sig L. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003; 92: 1049-55.
13. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103: 2885-90.
14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
15. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Ti-emann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Invest 2001; 108: 391-7.
16. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370-6.
17. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107: 3059-65.
18. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 2002; 90: 1243-50.
19. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, Sladek FM, et al. AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 2006; 26: 1281-7.
20. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of en-dothelial nitric oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997; 272: 18522-5.
21. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998; 273: 24266-71.